China and Taiwan strike broad deal on intellectual property
This article was originally published in Scrip
Executive Summary
China and Taiwan have signed a wide-ranging bilateral agreement on the protection of intellectual property rights (IPR), which lays down major principles with implications for many products, including pharmaceuticals.